By Ludwig Burger and Eva Mathews (Reuters) – Novo Nordisk will ration starter kits of Ozempic in Europe and reduce supplies of another diabetes drug, Victoza, to prioritise producing Ozempic, …
ozempic
-
-
By Blake Brittain WASHINGTON (Reuters) – A U.S. Patent Office tribunal on Monday rejected challenges to two key patents owned by Novo Nordisk covering the active ingredient in its weight-loss …
-
By Julie Steenhuysen CHICAGO (Reuters) – People taking popular diabetes and weight loss drugs such as Novo Nordisk’s Ozempic and Wegovy or Eli Lilly’s Mounjaro should temporarily stop taking them …
-
By Natalie Grover LONDON (Reuters) – Diabetes drugs that also promote weight loss such as Novo Nordisk’s Ozempic, becoming a darling of celebrities and investors, are being studied to tackle …
-
By Ludwig Burger (Reuters) – Danish drugmaker Novo Nordisk raised its full-year earnings outlook on strong sales of diabetes treatment Ozempic, also reporting a better-than-expected profit. In a statement on …